Marc S. Raab

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Marc S. Raab
Mar 10, 2025, 08:54 | Blog
Martin Kaiser: Co-occurrence of more than 2 HRCAs is associated with highest unmet need in NDMM and RRMM
Martin Kaiser, Reader in Molecular Haematology at The Institute of Cancer Research, shared an article…
Jan 15, 2025, 13:17 | Science
Myeloma Paper of the Day, January 15th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Long-term follow-up of Phase…
Jan 4, 2025, 17:44 | Insight
Top Moffitt Cancer Center Research Stories of 2024
Moffitt Cancer Center stands as Florida's sole National Cancer Institute Comprehensive Cancer Center, recognized for…
Dec 22, 2024, 10:00 | Science
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Francesco Maura, Assistant Professor of Sylvester Comprehensive Cancer Center, posted on X about recent paper…
Dec 10, 2024, 13:59 | Opinion
Rahul Banerjee: Safety run-in for Teclistamab and Lenalidomide maintenance after ASCT
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a post on X: “MajesTEC-4!…
Nov 9, 2024, 10:50 | Blog
Bone lesions in patients with high risk smoldering myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, posted on X…
Nov 4, 2024, 16:51 | Drugs
Rahul Banerjee: What Changes Once SQ Isatuximab Approved?
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Aug 29, 2024, 09:52 | Insight
Myeloma Paper of the Day, August 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: MGUS risk stratification models can…
All: 8 Posts: 1 - 100
Special Coverage